SYTL4 and cancer: It has been recently shown that LMP1 promotes EVs secretion and may enhance cancer progression and metastasis by up-regulating syndecan-2 (SDC2) and synaptotagmin-like-4 (SYTL4) through nuclear factor (NF)-κB signaling [154].